Retroperitoneal Cancer
Liposarcoma of Retroperitoneal Space
Female, 60 years
Patient Internal ID: 276082054
ICD-10 code
C48.0 Malignant Neoplasm of Retroperitoneum
Diagnosis (Incl. Metastases/Stage) and Year
May 2017
Liposarcoma of Retroperitoneal Space pT2bN0M0 G4 R1. Disease progression in July 2017, Metastasis in Peritoneal Space.
Previous Treatment
Surgery, Chemotherapy (Doxorubicin/Ifosfamide), Chemotherapy (Dacarbazine/ Gemcitabine), Surgery.
Prognosis and Survival Expectation
Liposarcomas are relatively rare tumors. The prognosis for Advanced Liposarcoma remains poor, with a median overall survival of ~15 months.
Treatment Provided
Autologous DCV (10 doses) over a period of 13 months.
Patient Survival/Condition and Year
Date of Review: 25/01/2024
The patient has survived for 62 months since the diagnosis and 60 months since disease progression. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 45 months.
